Bovine Mastitis - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511245704

Publication Date:

November 26, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Bovine mastitis is a medical disorder occurs in dairy cattle. It refers to the inflammation of mammary gland and udder tissue. The disease can damage milk-secreting tissues in the cattle; a primary reason why this is considered as a serious disorder.
The global market for Bovine Mastitis was estimated to be worth US$ 827 million in 2023 and is forecast to a readjusted size of US$ 1235.6 million by 2030 with a CAGR of 5.9% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bovine Mastitis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Bovine Mastitis by region & country, by Type, and by Application.
The Bovine Mastitis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bovine Mastitis.
麻豆原创 Segmentation
By Company
Zoetis
MSD Animal Health
Boehringer Ingelheim International
Bayer
Elanco
Ceva
West Way Health
Segment by Type:
Antibiotics
Others
Segment by Application
Lactating Period
Dry Period
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bovine Mastitis manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Bovine Mastitis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Bovine Mastitis in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Bovine Mastitis Product Introduction
1.2 Global Bovine Mastitis 麻豆原创 Size Forecast
1.3 Bovine Mastitis 麻豆原创 Trends & Drivers
1.3.1 Bovine Mastitis Industry Trends
1.3.2 Bovine Mastitis 麻豆原创 Drivers & Opportunity
1.3.3 Bovine Mastitis 麻豆原创 Challenges
1.3.4 Bovine Mastitis 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bovine Mastitis Players Revenue Ranking (2023)
2.2 Global Bovine Mastitis Revenue by Company (2019-2024)
2.3 Key Companies Bovine Mastitis Manufacturing Base Distribution and Headquarters
2.4 Key Companies Bovine Mastitis Product Offered
2.5 Key Companies Time to Begin Mass Production of Bovine Mastitis
2.6 Bovine Mastitis 麻豆原创 Competitive Analysis
2.6.1 Bovine Mastitis 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Bovine Mastitis Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bovine Mastitis as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Antibiotics
3.1.2 Others
3.2 Global Bovine Mastitis Sales Value by Type
3.2.1 Global Bovine Mastitis Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Bovine Mastitis Sales Value, by Type (2019-2030)
3.2.3 Global Bovine Mastitis Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Lactating Period
4.1.2 Dry Period
4.2 Global Bovine Mastitis Sales Value by Application
4.2.1 Global Bovine Mastitis Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Bovine Mastitis Sales Value, by Application (2019-2030)
4.2.3 Global Bovine Mastitis Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Bovine Mastitis Sales Value by Region
5.1.1 Global Bovine Mastitis Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Bovine Mastitis Sales Value by Region (2019-2024)
5.1.3 Global Bovine Mastitis Sales Value by Region (2025-2030)
5.1.4 Global Bovine Mastitis Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Bovine Mastitis Sales Value, 2019-2030
5.2.2 North America Bovine Mastitis Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Bovine Mastitis Sales Value, 2019-2030
5.3.2 Europe Bovine Mastitis Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Bovine Mastitis Sales Value, 2019-2030
5.4.2 Asia Pacific Bovine Mastitis Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Bovine Mastitis Sales Value, 2019-2030
5.5.2 South America Bovine Mastitis Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Bovine Mastitis Sales Value, 2019-2030
5.6.2 Middle East & Africa Bovine Mastitis Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bovine Mastitis Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Bovine Mastitis Sales Value
6.3 United States
6.3.1 United States Bovine Mastitis Sales Value, 2019-2030
6.3.2 United States Bovine Mastitis Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Bovine Mastitis Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Bovine Mastitis Sales Value, 2019-2030
6.4.2 Europe Bovine Mastitis Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Bovine Mastitis Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Bovine Mastitis Sales Value, 2019-2030
6.5.2 China Bovine Mastitis Sales Value by Type (%), 2023 VS 2030
6.5.3 China Bovine Mastitis Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Bovine Mastitis Sales Value, 2019-2030
6.6.2 Japan Bovine Mastitis Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Bovine Mastitis Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Bovine Mastitis Sales Value, 2019-2030
6.7.2 South Korea Bovine Mastitis Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Bovine Mastitis Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Bovine Mastitis Sales Value, 2019-2030
6.8.2 Southeast Asia Bovine Mastitis Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Bovine Mastitis Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Bovine Mastitis Sales Value, 2019-2030
6.9.2 India Bovine Mastitis Sales Value by Type (%), 2023 VS 2030
6.9.3 India Bovine Mastitis Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Profile
7.1.2 Zoetis Main Business
7.1.3 Zoetis Bovine Mastitis Products, Services and Solutions
7.1.4 Zoetis Bovine Mastitis Revenue (US$ Million) & (2019-2024)
7.1.5 Zoetis Recent Developments
7.2 MSD Animal Health
7.2.1 MSD Animal Health Profile
7.2.2 MSD Animal Health Main Business
7.2.3 MSD Animal Health Bovine Mastitis Products, Services and Solutions
7.2.4 MSD Animal Health Bovine Mastitis Revenue (US$ Million) & (2019-2024)
7.2.5 MSD Animal Health Recent Developments
7.3 Boehringer Ingelheim International
7.3.1 Boehringer Ingelheim International Profile
7.3.2 Boehringer Ingelheim International Main Business
7.3.3 Boehringer Ingelheim International Bovine Mastitis Products, Services and Solutions
7.3.4 Boehringer Ingelheim International Bovine Mastitis Revenue (US$ Million) & (2019-2024)
7.3.5 Bayer Recent Developments
7.4 Bayer
7.4.1 Bayer Profile
7.4.2 Bayer Main Business
7.4.3 Bayer Bovine Mastitis Products, Services and Solutions
7.4.4 Bayer Bovine Mastitis Revenue (US$ Million) & (2019-2024)
7.4.5 Bayer Recent Developments
7.5 Elanco
7.5.1 Elanco Profile
7.5.2 Elanco Main Business
7.5.3 Elanco Bovine Mastitis Products, Services and Solutions
7.5.4 Elanco Bovine Mastitis Revenue (US$ Million) & (2019-2024)
7.5.5 Elanco Recent Developments
7.6 Ceva
7.6.1 Ceva Profile
7.6.2 Ceva Main Business
7.6.3 Ceva Bovine Mastitis Products, Services and Solutions
7.6.4 Ceva Bovine Mastitis Revenue (US$ Million) & (2019-2024)
7.6.5 Ceva Recent Developments
7.7 West Way Health
7.7.1 West Way Health Profile
7.7.2 West Way Health Main Business
7.7.3 West Way Health Bovine Mastitis Products, Services and Solutions
7.7.4 West Way Health Bovine Mastitis Revenue (US$ Million) & (2019-2024)
7.7.5 West Way Health Recent Developments
8 Industry Chain Analysis
8.1 Bovine Mastitis Industrial Chain
8.2 Bovine Mastitis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Bovine Mastitis Sales Model
8.5.2 Sales Channel
8.5.3 Bovine Mastitis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Zoetis
MSD Animal Health
Boehringer Ingelheim International
Bayer
Elanco
Ceva
West Way Health

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.